Clinical Trials Directory

Trials / Completed

CompletedNCT02459535

Immediate and Long-term Induction of Incretin Release by Artificial Sweeteners 1

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
German Institute of Human Nutrition · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Epidemiological data suggest, that not only sugar-based, but also artificially sweetened soft drinks may play a role in the development of diabetes. Recent studies in animals and humans have shown, that artificial sweeteners (AS) influence metabolic responses after glucose ingestion, possibly alter the intestinal microbiome and even modulate incretin release. However, it is unclear, if these findings are valid for all kinds of AS, as they are chemically different. Furthermore, data on human subjects are sparse and controversial. The investigators will therefore conduct 7 consecutive single oral stimulations with glucose or AS alone or a combination. Three different AS will be tested.

Detailed description

Epidemiological data suggest, that not only sugar-based, but also artificially sweetened soft drinks may play a role in the development of diabetes. Recent studies in animals and humans have shown, that artificial sweeteners (AS) influence metabolic responses after glucose ingestion, possibly alter the intestinal microbiome and even modulate incretin release. However, it is unclear, if these findings are valid for all kinds of AS, as they are chemically different. Up to now, no single study has ever compared metabolic responses to different AS in the same subjects. Furthermore, data on human subjects are sparse and controversial. This is partially explained by different methodical approaches such as intragastral/intraduodenal application of AS, rather than conventional oral consumption. The investigators will therefore conduct 7 consecutive single oral stimulations with glucose or AS alone or a combination. Three different AS will be tested: saccharin, aspartame and sucralose.

Conditions

Interventions

TypeNameDescription
OTHERoral stimulation glucoseoral stimulation with glucose, AS or glucose+AS in fasted state, blood samples from fasted state up to 120 min post-ingestion
OTHERoral stimulation saccharin
OTHERoral stimulation aspartame
OTHERoral stimulation sucralose

Timeline

Start date
2015-03-01
Primary completion
2017-06-01
Completion
2019-07-01
First posted
2015-06-02
Last updated
2020-06-24

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02459535. Inclusion in this directory is not an endorsement.